复方番石榴合剂治疗超重肥胖型2型糖尿病疗效及对患者肠黏膜屏障功能的影响  

Effects of compound Fanshiliu mixture on clinical efficacy and intestinal mucosal barrier function in patients with overweight-obesity complicated with type 2 diabetes mellitus

作　　者：徐瑞颜[1] 成金燕[1] 李乐愚[1] XU Ruiyan;CHENG Jinyan;LI Leyu(Department of Endocrinology and Metabolism,Zhongshan Hospital of Traditional Chinese Medicine,Affiliated to Guangzhou University of Chinese Medicine,Zhongshan 528400,China)

机构地区：[1]广州中医药大学附属中山市中医院内分泌代谢科,广东中山528400

出　　处：《陕西中医》2022年第8期1045-1048,共4页Shaanxi Journal of Traditional Chinese Medicine

基　　金：广东省中医药管理局科研项目(20182170);广东省中山市社会公益科技研究项目(2019B1044)。

摘　　要：目的:探究复方番石榴合剂对超重肥胖型2型糖尿病患者中医临床疗效及肠黏膜屏障功能的影响。方法:选取100例脾虚胃热证超重肥胖型2型糖尿病患者为研究对象,遵循随机分组的原则,分为观察组和对照组,各50例。对照组予二甲双胍肠溶片和/或胰岛素基础治疗,观察组在对照组的基础上使用复方番石榴制剂联合治疗。比较两组患者治疗后临床疗效差异,评估两组患者治疗前后中医证候积分(心下痞满、胀闷呕恶、呃逆、水谷不消、纳呆、便溏)、肠黏膜屏障功能[二胺氧化酶(DAO)、脂多糖(LPS)、D-乳酸(DLC)]变化,分析两组患者治疗期间药物不良反应差异。结果:治疗12周后,观察组患者总有效率高于对照组(P<0.05);治疗12周后,两组患者中医证候积分及DAO、LPS、DLC等肠黏膜屏障功能指标均较治疗前下降,且观察组低于同期对照组(P<0.05);治疗期间,两组患者腹胀腹泻、胃部不适、恶心呕吐发生率及总发生率比较,差异无统计学意义(P>0.05)。结论:复方番石榴合剂治疗超重肥胖型2型糖尿病患者可有效减轻患者中医症状,且能调节肠黏膜屏障功能。Objective:To explore the effects of compound Fanshiliu mixture on TCM clinical efficacy and intestinal mucosal barrier function in patients with overweight-obesity complicated with type 2 diabetes mellitus.Methods:100 patients with overweight-obesity complicated with type 2 diabetes mellitus of spleen deficiency and stomach heat syndrome were selected as the research subjects,and they were divided into the observation group(n=50)and the control group(n=50)by following the principle of random grouping.The control group was given metformin enteric-coated tablets and/or insulin basal therapy,while the observation group was combined with compound Fanshiliu mixture on the basis of the control group.The clinical efficacy of the two groups of patients was compared after treatment,and the changes in scores of TCM syndromes(epigastric fullness,distension and nausea,hiccup,indigestion of essence of water and grain,anorexia,loose stool)and intestinal mucosal barrier function[diamine oxidase(DAO),lipopolysaccharide(LPS),D-lactic acid(DLC)]were evaluated in the two groups before and after treatment.The differences in adverse drug reactions were analyzed in the two groups of patients during treatment.Results:After 12 weeks of treatment,the total effective rate in the observation group was higher than that in the control group(P<0.05).After 12 weeks of treatment,the scores of TCM syndromes and levels of intestinal mucosal barrier function indicators of DAO,LPS and DLC in the two groups were reduced compared with those before treatment,and the scores and levels in the observation group were lower compared with those in the control group(P<0.05).Within 12 weeks of treatment,there were no statistical differences in the incidence rates of abdominal distension and diarrhea,stomach discomfort and nausea and vomiting and total incidence rate between the two groups of patients(P>0.05).Conclusion:Compound Fanshiliu mixture in the treatment of patients with overweight-obesity complicated with type 2 diabetes mellitus can effectively reli

关 键 词：2型糖尿病 超重肥胖 复方番石榴合剂 肠黏膜屏障功能 二胺氧化酶 脂多糖 D-乳酸 

分 类 号：R587.1[医药卫生—内分泌]